EFFICACY AND SAFETY OF GLP-1 ANALOGS Although there are no studies of the long-term efficacy of DPP-IV inhibitors on -cell function, in short-term studies ranging from several months to 1 year, both sitagliptin and vildagliptin demonstrated a reduction in postprandial plasma glucose concentrations while maintaining plasma insulin response, indicating a positive effect on -cell function [13-15]
If you experience any suspected side effects from GLP-1 medications, you can report them through the MHRA Yellow Card scheme, which helps monitor medication safety
Gallstone risk is a known class-level signal with rapid weight loss
I used to be a much bigger person and the story around that feels like a character defect rather than science, she says
Wren - Jun 7th 2026 5 I was very pleased with this serum Its lightweight, non-greasy, and feels much more comfortable than many other serums I've tried
However, postprandial hyperglycemia is still very common in people with T2D even when the overall glycemic profile seems to be good